Integra Lifesciences Initiates Voluntary Global Recall Of All Products Made In Boston Facility Distributed Between Mar. 1, 2018 And May 22; ExpectsImpairment Charge Related To Write-Off Of Inventories, Net, Of ~$22M
Portfolio Pulse from Benzinga Newsdesk
Integra Lifesciences has initiated a voluntary global recall of all products made in its Boston facility between March 1, 2018, and May 22. The company expects an impairment charge related to the write-off of inventories, net, of approximately $22 million.
May 23, 2023 | 10:36 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Integra Lifesciences' voluntary global recall of products made in its Boston facility may negatively impact its stock price due to the expected $22 million impairment charge.
The voluntary global recall of products made in Integra Lifesciences' Boston facility is expected to result in a significant impairment charge of approximately $22 million. This financial impact may lead to a negative short-term effect on the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100